C122H151ClN20O9 — CID 91290423
(2S)-2-amino-2-phenylacetamide;1-methylpiperazine;trans-(1R,2R)-N-[(1S)-2-amino-2-oxo-1-phenylethyl]-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxamide;trans-methyl (1R,2R)-2-[4-[(2-chlorobenzimidazol-1-yl)methyl]phenyl]cyclohexane-1-carboxylate;trans-methyl (1R,2R)-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxylate;trans-(1R,2R)-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxylic acid (PubChem CID 91290423) has the molecular formula C122H151ClN20O9 and a molecular weight of 2077.13 g/mol. Its IUPAC name is (2S)-2-amino-2-phenylacetamide;1-methylpiperazine;trans-(1R,2R)-N-[(1S)-2-amino-2-oxo-1-phenylethyl]-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxamide;trans-methyl (1R,2R)-2-[4-[(2-chlorobenzimidazol-1-yl)methyl]phenyl]cyclohexane-1-carboxylate;trans-methyl (1R,2R)-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxylate;trans-(1R,2R)-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxylic acid.
| Compound Name | (2S)-2-amino-2-phenylacetamide;1-methylpiperazine;trans-(1R,2R)-N-[(1S)-2-amino-2-oxo-1-phenylethyl]-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxamide;trans-methyl (1R,2R)-2-[4-[(2-chlorobenzimidazol-1-yl)methyl]phenyl]cyclohexane-1-carboxylate;trans-methyl (1R,2R)-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxylate;trans-(1R,2R)-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxylic acid |
|---|---|
| PubChem CID | 91290423 |
| Molecular Formula | C122H151ClN20O9 |
| Molecular Weight | 2077.13 g/mol |
| Exact Mass | 2075.17 |
| IUPAC Name | (2S)-2-amino-2-phenylacetamide;1-methylpiperazine;trans-(1R,2R)-N-[(1S)-2-amino-2-oxo-1-phenylethyl]-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxamide;trans-methyl (1R,2R)-2-[4-[(2-chlorobenzimidazol-1-yl)methyl]phenyl]cyclohexane-1-carboxylate;trans-methyl (1R,2R)-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxylate;trans-(1R,2R)-2-[4-[[2-(4-methylpiperazin-1-yl)benzimidazol-1-yl]methyl]phenyl]cyclohexane-1-carboxylic acid |
| SMILES | CN1CCN(c2nc3ccccc3n2Cc2ccc([C@@H]3CCCC[C@H]3C(=O)N[C@H](C(N)=O)c3ccccc3)cc2)CC1.CN1CCN(c2nc3ccccc3n2Cc2ccc([C@@H]3CCCC[C@H]3C(=O)O)cc2)CC1.CN1CCNCC1.COC(=O)[C@@H]1CCCC[C@H]1c1ccc(Cn2c(Cl)nc3ccccc32)cc1.COC(=O)[C@@H]1CCCC[C@H]1c1ccc(Cn2c(N3CCN(C)CC3)nc3ccccc32)cc1.NC(=O)[C@@H](N)c1ccccc1 |
| InChI | InChI=1S/C34H40N6O2.C27H34N4O2.C26H32N4O2.C22H23ClN2O2.C8H10N2O.C5H12N2/c1-38-19-21-39(22-20-38)34-36-29-13-7-8-14-30(29)40(34)23-24-15-17-25(18-16-24)27-11-5-6-12-28(27)33(42)37-31(32(35)41)26-9-3-2-4-10-26;1-29-15-17-30(18-16-29)27-28-24-9-5-6-10-25(24)31(27)19-20-11-13-21(14-12-20)22-7-3-4-8-23(22)26(32)33-2;1-28-14-16-29(17-15-28)26-27-23-8-4-5-9-24(23)30(26)18-19-10-12-20(13-11-19)21-6-2-3-7-22(21)25(31)32;1-27-21(26)18-7-3-2-6-17(18)16-12-10-15(11-13-16)14-25-20-9-5-4-8-19(20)24-22(25)23;9-7(8(10)11)6-4-2-1-3-5-6;1-7-4-2-6-3-5-7/h2-4,7-10,13-18,27-28,31H,5-6,11-12,19-23H2,1H3,(H2,35,41)(H,37,42);5-6,9-14,22-23H,3-4,7-8,15-19H2,1-2H3;4-5,8-13,21-22H,2-3,6-7,14-18H2,1H3,(H,31,32);4-5,8-13,17-18H,2-3,6-7,14H2,1H3;1-5,7H,9H2,(H2,10,11);6H,2-5H2,1H3/t27-,28+,31-;22-,23+;21-,22+;17-,18+;7-;/m00000./s1 |
| InChIKey | XQKAOHTYTLIGAO-QWCLJDAFSA-N |
| XLogP | 17.81 |
| TPSA | 337.19 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 152 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2077.13 |
| LogP ≤ 5 | 17.81 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 25 |